What is Orbit Discovery?
Orbit Discovery is a biopharmaceutical company based in Oxford, United Kingdom, focused on developing a novel platform for screening peptide libraries. Their technology enables the identification of peptides that bind to specific targets and exhibit subsequent activity in cell-based functional assays. This capability is crucial for drug discovery and development, allowing for more efficient and targeted therapeutic research. The company's work positions it at the forefront of precision medicine and advanced drug development methodologies.
How much funding has Orbit Discovery raised?
Orbit Discovery has raised a total of $16.3M across 2 funding rounds:
Series A
$8.7M
Unspecified
$7.6M
Series A (2018): $8.7M with participation from Perivoli Innovations, RT Ventures, Borealis Ventures, Oxford Sciences Innovation, and Oxford University
Unspecified (2021): $7.6M led by Perivoli Innovations, Oxford Sciences Enterprises, and Borealis Ventures
Key Investors in Orbit Discovery
Perivoli Innovations
Perivoli Innovations is a venture investment trust focused on early-stage investments in medical, life science, and technology sectors, with a commitment to positive social impact and donating profits to charity.
Oxford Sciences Enterprises
Oxford Science Enterprises is an investment company partnered with the University of Oxford, dedicated to founding, funding, and building transformational businesses from world-class research.
Borealis Ventures
Borealis Ventures focuses on building visionary healthcare companies by providing essential elements for success and supporting innovative solutions in the healthcare field.
What's next for Orbit Discovery?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Orbit Discovery. This capital infusion is expected to accelerate the development and commercialization of their peptide screening platform, potentially leading to new therapeutic breakthroughs. The company is likely to expand its research and development capabilities, forge strategic partnerships, and advance its pipeline of drug candidates. Orbit Discovery's trajectory suggests a move towards scaling operations and solidifying its market position in the competitive biopharmaceutical landscape.
See full Orbit Discovery company page
